Suppr超能文献

社会关系在跨性别女性和男男性行为者中接受和使用 PrEP 中的作用。

The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men.

机构信息

J. David Gladstone Institutes, 1650 Owens Street, San Francisco, CA, 94158, USA.

University of California, San Francisco, CA, USA.

出版信息

AIDS Behav. 2018 Nov;22(11):3673-3680. doi: 10.1007/s10461-018-2151-0.

Abstract

Qualitative studies suggest that social relationships play an important role in HIV pre-exposure prophylaxis (PrEP) use, but there have been few quantitative assessments of the role of social relationships in PrEP uptake or adherence. We examined the association between disclosure of study participation or LGBT identity and PrEP use in the 1603 HIV-negative participants enrolled in the iPrEx OLE study. We also evaluated the association between LGBT social group involvement and PrEP use. Study participation disclosure to parents and LGBT identity disclosure to anyone in a participant's social network were associated with greater PrEP uptake. Study participation disclosure to partners was associated with higher probability of having protective PrEP drug concentrations compared [risk difference 0.15 95% CI (0.01, 0.30)]. For each additional type of LGBT organization a participant was involved in, the probability of PrEP uptake and having protective drug concentrations increased by 0.04 [95% CI (0.03, 0.06)] and 0.04 (95% CI (0.02, 0.07)] respectively. Overall, social context was associated with PrEP use in iPrEx OLE, and should be taken into consideration when designing future PrEP implementation programs.

摘要

定性研究表明,社会关系在 HIV 暴露前预防(PrEP)的使用中起着重要作用,但很少有定量评估社会关系在 PrEP 使用率或坚持率方面的作用。我们研究了在 iPrEx OLE 研究中招募的 1603 名 HIV 阴性参与者中,研究参与的披露或 LGBT 身份与 PrEP 使用之间的关联。我们还评估了 LGBT 社会团体参与与 PrEP 使用之间的关联。向父母披露研究参与情况和向参与者社交网络中的任何人披露 LGBT 身份与更高的 PrEP 使用率相关。与伴侣披露研究参与情况与具有保护作用的 PrEP 药物浓度的可能性更高相关[风险差异 0.15 95%CI(0.01,0.30)]。参与者参与的每增加一个 LGBT 组织,PrEP 使用率和具有保护作用的药物浓度的可能性分别增加 0.04[95%CI(0.03,0.06)]和 0.04(95%CI(0.02,0.07)]。总体而言,社会背景与 iPrEx OLE 中的 PrEP 使用相关,在设计未来的 PrEP 实施计划时应考虑到这一点。

相似文献

3
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.
4
Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
J Adolesc Health. 2020 Mar;66(3):268-274. doi: 10.1016/j.jadohealth.2019.08.014. Epub 2019 Oct 28.
8
Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
AIDS Behav. 2019 Oct;23(10):2719-2729. doi: 10.1007/s10461-019-02502-y.
9
Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
AIDS Patient Care STDS. 2019 Jun;33(6):262-269. doi: 10.1089/apc.2019.0049.

引用本文的文献

5
Determinants of Preexposure Prophylaxis Cascade Among Sexual and Gender Minorities in Nigeria.
Sex Transm Dis. 2023 Sep 1;50(9):559-566. doi: 10.1097/OLQ.0000000000001841. Epub 2023 Jun 6.
8
A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.
Drug Alcohol Depend. 2022 Sep 1;238:109585. doi: 10.1016/j.drugalcdep.2022.109585. Epub 2022 Jul 23.
9
Social identity support, descriptive norms, and economic instability in PrEP engagement for emerging adult MSM in the United States.
AIDS Care. 2022 Nov;34(11):1452-1460. doi: 10.1080/09540121.2022.2075821. Epub 2022 Jun 28.

本文引用的文献

1
Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi.
PLoS One. 2017 Feb 21;12(2):e0172354. doi: 10.1371/journal.pone.0172354. eCollection 2017.
2
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6692-6697. doi: 10.1128/AAC.01017-16. Print 2016 Nov.
4
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.
6
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):528-37. doi: 10.1097/QAI.0000000000000351.
7
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.
8
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):340-8. doi: 10.1097/QAI.0000000000000172.
9
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):447-56. doi: 10.1097/QAI.0b013e3182801081.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验